Latest debt-to-equity ratio
bioAffinity Technologies Debt-to-equity ratio
Direct answer
bioAffinity Technologies's debt-to-equity ratio is 38.08%.
The verified market snapshot reports 38.08%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free bioAffinity Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 38.08%
Explore related company data
View bioAffinity Technologies's market capitalizationView bioAffinity Technologies's price-to-book ratioView bioAffinity Technologies's return on equityView bioAffinity Technologies's dividend yieldView bioAffinity Technologies's 52-week price rangeView bioAffinity Technologies's revenue growthView bioAffinity Technologies's profit marginView all bioAffinity Technologies key metricsReturn to bioAffinity Technologies profile